Concepedia

Roberto Murialdo

RM

24

Publications

1.2K

Citations

19

H-Index

2003

Active since

Affiliations

Ospedale Policlinico San Martino(Current)

University of Genoa

Fondazione IRCCS Istituto Nazionale dei Tumori

Istituto Oncologico Veneto

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Roberto Murialdo is an author at Ospedale Policlinico San Martino specializing in medicine, cancer research, and oncology.

Top concepts

Publications per year

2003–2022

24

Publications

24

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti et al. · British Journal of Cancer · 2020 · 315 citations · Full text

Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With <i>RAS</i> Wild-Type Metastatic Colorectal Cancer

Filippo Pietrantonio, Federica Morano, Salvatore Corallo et al. · JAMA Oncology · 2019 · 103 citations · Full text

Negative Hyperselection of Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

Federica Morano, Salvatore Corallo, Sara Lonardi et al. · Journal of Clinical Oncology · 2019 · 103 citations · Full text

Serum enterolactone levels and the risk of breast cancer in women with palpable cysts

Francesco Boccardo, G. Lunardi, Pamela Guglielmini et al. · European Journal of Cancer · 2003 · 75 citations

, , +7

5‐fluorouracil causes endothelial cell senescence: potential protective role of glucagon‐like peptide 1

Paola Altieri, Roberto Murialdo, Chiara Barisione et al. · British Journal of Pharmacology · 2017 · 70 citations · Full text

Rows per page

1–5 of 24